Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)
NEW YORK, Nov. 20, 2012 /PRNewswire/ --
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.
JDA Software Group Inc.
Levi & Korsinsky is investigating the Board of Directors of JDA Software Group Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to RedPrairie Corp. for $45 per share.
Click here to learn more about the investigation http://zlk.9nl.com/jda-software, or call: 877-363-5972.
Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.
For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
RELATED LINKS
http://www.zlk.com
More by this Source
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by Board of Belo Corp. in Connection with the Sale of the Company to Gannett Co., Inc.
Jun 13, 2013, 17:26 ET
DOLE FOOD COMPANY SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Dole Food Company, Inc. in Connection with Going Private Proposal from Company's CEO
Jun 13, 2013, 17:24 ET
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Autoliv, Inc. of Class Action Lawsuit and the Deadline of June 17, 2013 to Seek a Lead Plaintiff Position
Jun 13, 2013, 14:33 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.